Surgical Science Sweden AB (publ) (FRA:4P41)
Germany flag Germany · Delayed Price · Currency is EUR
3.150
+0.066 (2.14%)
Last updated: Feb 23, 2026, 9:55 AM CET

FRA:4P41 Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
66.82131.65233.97187.9786.25
Depreciation & Amortization
83.3741.3638.435.6623.9
Other Amortization
-19.1517.2115.939.62
Other Operating Activities
-8.710.95-45.64-44.46-34
Change in Accounts Receivable
-87.61-20.2431.91-70.76-84.57
Change in Inventory
-16.39-11.56-19.57-21.726.46
Change in Other Net Operating Assets
42.31-34.09-17.9926.8731.43
Operating Cash Flow
79.8137.23238.29129.4939.08
Operating Cash Flow Growth
-41.85%-42.41%84.03%231.31%68.28%
Capital Expenditures
-11.68-6.1-10.46-9.35-3.87
Cash Acquisitions
-84.91----2,718
Sale (Purchase) of Intangibles
-37.66-41.43-33.67-25.2-10.51
Other Investing Activities
0----
Investing Cash Flow
-134.25-47.53-44.13-34.55-2,733
Long-Term Debt Issued
-235.41-17.09-
Long-Term Debt Repaid
-259.72-2.23-1.26--31.72
Total Debt Repaid
-259.72-2.23-1.26--31.72
Net Debt Issued (Repaid)
-259.72233.18-1.2617.09-31.72
Issuance of Common Stock
----3,039
Other Financing Activities
0.05-5.5317.11--84.87
Financing Cash Flow
-259.68227.6515.8517.092,922
Foreign Exchange Rate Adjustments
-37.616.44-9.385.020.59
Net Cash Flow
-351.73333.79200.63117.05229.52
Free Cash Flow
68.12131.12227.84120.1435.21
Free Cash Flow Growth
-48.05%-42.45%89.65%241.18%54.26%
Free Cash Flow Margin
6.86%14.83%25.81%14.97%9.60%
Free Cash Flow Per Share
1.332.574.472.360.82
Cash Income Tax Paid
49.527.6914.558.483.43
Levered Free Cash Flow
-217.78279.4794.1495.8617.79
Unlevered Free Cash Flow
-213.91279.9494.5596.1918.11
Change in Working Capital
-61.7-65.89-5.65-65.61-46.69
Source: S&P Global Market Intelligence. Standard template. Financial Sources.